A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab Plus Docetaxel Versus Placebo Plus Docetaxel in Patients With Locally Advanced or Unresectable or Metastatic Urothelial Carcinoma Who Progressed on or After Platinum-Based Therapy
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007476/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and efficacy of the study drug
ramucirumab in combination with docetaxel in participants with urothelial cancer who failed
prior platinum-based therapy.
提供机构：
Vivli
创建时间：
2021-10-22
